InsiderTrades

Form 4 for HCAT Health Catalyst, Inc.

Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0001562180-22-000329 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-01-06 2022-01-04 HCAT Llewelyn Linda CHRO S - Sale+OE $40.23 -3,234 30.9K -9% -$130.1K
DM 2022-01-06 2022-01-04 HCAT Llewelyn Linda CHRO M - OptEx $11.14 +3,150 34.1K +10% +$35.1K
DM 2022-01-06 2022-01-04 HCAT Llewelyn Linda CHRO M - OptEx $0.00 -3,150 4,754 -40% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-04 S D 3,234 $40.23 30,882 D — —
2 Common Common Stock 2022-01-04 M A 2,050 $10.80 33,016 D — —
3 Common Common Stock 2022-01-04 M A 1,100 $11.78 34,116 D — —
4 Derivative Stock Option (Right to Buy) 2022-01-04 M D 2,050 $0.00 6,920 D $10.80 · — to 2028-09-27 950 Common Stock (F3) 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
5 Derivative Stock Option (Right to Buy) 2022-01-04 M D 1,100 $0.00 4,754 D $11.78 · — to 2028-01-24 1,100 Common Stock (F2) 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.